No information is available on the clinical use of semaglutide during breastfeeding. Because semaglutide is a peptide molecule with a molecular weight of 4113 Da and is over 99% protein bound, the amount in milk is likely to be very low. Furthermore, semaglutide is only 0.4% to 1% orally absorbed, so it is unlikely to adversely affect the breastfed infant.